S Vandel
Impact in
- Pharmacology top 2%
- Treatment of Major Depression
- Pharmacogenetics and Drug Metabolism
- Psychiatry and Mental health top 5%
- Schizophrenia research and treatment
- Electroconvulsive Therapy Studies
- Bipolar Disorder and Treatment
- Epilepsy research and treatment
Papers in
-
- Electroconvulsive Therapy Studies 12
- Bipolar Disorder and Treatment 11
- Schizophrenia research and treatment 11
- Epilepsy research and treatment 9
- Pharmacology 28
- Treatment of Major Depression 24
- Pharmacogenetics and Drug Metabolism 7
- Co-authors
- B Vandel (26 shared papers)R Volmat (22 shared papers)G Allers (18 shared papers)Gilles Bertschy (28 shared papers)P Bízouard (21 shared papers)P Bechtel (8 shared papers)D. Sechter (16 shared papers)Pierre Vandel (15 shared papers)
- Journals
- European Journal of Clinical Pharmacology (9 papers)Pharmacopsychiatry (5 papers)Clinical Infectious Diseases (2 papers)Clinical Neuropharmacology (2 papers)European Psychiatry (2 papers)
- Partner nations
- FranceSwitzerlandNew Zealand
In The Last Decade
S Vandel
69 papers receiving 729 citations
Peers
Comparison fields: 5 of 86
- Pharmacology 217
- Psychiatry and Mental health 295
- Pharmacology 301
- Biological Psychiatry 38
- Cellular and Molecular Neuroscience 105
Countries citing papers authored by S Vandel
This map shows the geographic impact of S Vandel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Vandel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Vandel more than expected).
Fields of papers citing papers by S Vandel
This network shows the impact of papers produced by S Vandel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Vandel. The network helps show where S Vandel may publish in the future.
Co-authors
The 25 scholars most cited alongside S Vandel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 74 | |
| 2 | 1995 | 66 | |
| 3 | 1978 | 51 | |
| 4 | 1992 | 43 | |
| 5 | 1998 | 41 | |
| 6 | 1999 | 38 | |
| 7 | 1979 | 38 | |
| 8 | 1982 | 36 | |
| 9 | 1982 | 33 | |
| 10 | 1989 | 25 | |
| 11 | 1974 | 22 | |
| 12 | Carbamazepine, fluvoxamine. Is there a pharmacokinetic interaction? | 1992 | 21 |
| 13 | SSRI-induced bleeding: two case reports. | 2001 | 19 |
| 14 | 1984 | 15 | |
| 15 | Debrisoquine and dextromethorphan phenotyping and antidepressant treatment. | 1991 | 14 |
| 16 | Valpromide increases the plasma concentrations of amitriptyline and its metabolite nortriptyline in depressive patients. | 1988 | 13 |
| 17 | 1983 | 12 | |
| 18 | 1999 | 10 | |
| 19 | 1981 | 10 | |
| 20 | [Prediction of suicide risk]. | 1991 | 10 |
About S Vandel
S Vandel is a scholar working on Psychiatry and Mental health, Pharmacology, Pediatrics, Perinatology and Child Health, Physiology and Cellular and Molecular Neuroscience, having authored 74 papers that have together received 783 indexed citations. Recurring topics across this work include Treatment of Major Depression (24 papers), Electroconvulsive Therapy Studies (12 papers), Bipolar Disorder and Treatment (11 papers), Schizophrenia research and treatment (11 papers), Epilepsy research and treatment (9 papers), Pharmacological Effects and Toxicity Studies (8 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). The work is most often cited by research in Pharmacology (217 citations), Psychiatry and Mental health (295 citations), Pharmacology (301 citations), Biological Psychiatry (38 citations) and Cellular and Molecular Neuroscience (105 citations). S Vandel has collaborated with scholars based in France, Switzerland and New Zealand. Frequent co-authors include B Vandel, R Volmat, G Allers, Gilles Bertschy, P Bízouard, P Bechtel, D. Sechter, Pierre Vandel, B Bonin and C Drobacheff. Their work appears in journals such as European Journal of Clinical Pharmacology, Pharmacopsychiatry, Clinical Infectious Diseases, Clinical Neuropharmacology and European Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.